Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Rhabdoid Tumor × Vincristine × Clear all

Phase

Status

Completed 3 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 15 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Burkitt Lymphoma 11 Lymphoma 9 Lymphoma, Follicular 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasms 5 Lymphoma, B-Cell 5 Medulloblastoma 4 Hodgkin Disease 4 Recurrence 3 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Retinoblastoma 2 Neuroectodermal Tumors, Primitive 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma, AIDS-Related 2 Leukemia, Myeloid, Accelerated Phase 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Biphenotypic, Acute 2 Leukemia 2 Hepatoblastoma 2 Central Nervous System Neoplasms 2 Brain Neoplasms 2 Blast Crisis 2 Wilms Tumor 1 Rhabdomyosarcoma, Embryonal 1

Interventions

X-Rays 6 Phantoms, Imaging 6 Magnetic Resonance Spectroscopy 6 Specimen Handling 5 Nuclear Medicine Department, Hospital 5 Biopsy 4 Cyclophosphamide 3 ulixertinib 2 tipifarnib 2 selpercatinib 2 palbociclib 2 larotrectinib 2 ivosidenib 2 etoposide phosphate 2 erdafitinib 2 ensartinib 2 Topotecan 2 Etoposide 2 tazemetostat 1 pembrolizumab 1 olaparib 1 atezolizumab 1 Vincristine 1 Vemurafenib 1 Tiragolumab 1 Temozolomide 1 Sirolimus 1 Radiotherapy 1 Pharmacogenomic Variants 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02114229 2026-03-17

SJATRT

St. Jude Children's Research Hospital

Phase 2 Active not recruiting

Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡